Related Experiment Video
Updated: Aug 11, 2026

Analytical Techniques for Assaying Nitric Oxide Bioactivity
Published on: June 18, 2012
Endogenously produced nitric oxide inhibits endothelial cell growth as demonstrated using novel antisense cell lines
J E Cartwright1, A P Johnstone, G S Whitley
1Department of Biochemistry and Immunology, St. George's Hospital Medical School, Cranmer Terrace, London, SW17 ORE. j.cartwright@sghms.ac.uk
Abstract:
Proliferation of endothelial cells is a vital component of vascular repair and angiogenesis. The endothelial cell mediator, nitric oxide (NO) has been reported both to inhibit and to promote endothelial cell proliferation. In this study we have generated cell lines which constitutively express antisense RNA to a region of inducible nitric oxide synthase (iNOS) from a murine endothelial cell line, sEnd-1. In response to stimulation with lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma) these antisense cells had no detectable RNA for endogenous iNOS, barely detectable iNOS protein and produced 82% less NO than did the control transfected line. Stimulation of the control transfected line caused significant NO production and inhibition of cell growth whereas for the antisense line, producing little NO in response to stimulation, proliferation remained the same as for unstimulated cells. No differences in cell death were observed between unstimulated and LPS/IFN-gamma stimulated cells. The data presented in this study directly demonstrate that NO derived endogenously from iNOS inhibits proliferation of endothelial cells. This approach overcomes problems in other studies where NO donors or non-isoform specific inhibitors of NO synthase have been used.
Insights
Nitric oxide (NO) derived from inducible nitric oxide synthase (iNOS) inhibits endothelial cell proliferation. This study demonstrates NO
Area of Science:
- Endothelial cell biology
- Vascular repair and angiogenesis
- Nitric oxide signaling
Background:
- Endothelial cell proliferation is crucial for vascular repair and angiogenesis.
- The role of nitric oxide (NO) in endothelial cell proliferation is debated, with conflicting reports suggesting both inhibitory and promotional effects.
- Inducible nitric oxide synthase (iNOS) is a key enzyme in NO production within endothelial cells.
Purpose of the Study:
- To investigate the direct effect of endogenously produced NO from iNOS on endothelial cell proliferation.
- To generate and characterize endothelial cell lines with suppressed iNOS expression.
- To clarify the specific role of iNOS-derived NO in regulating endothelial cell growth.
Main Methods:
- Generation of murine endothelial cell lines (sEnd-1) stably expressing antisense RNA against iNOS.
- Stimulation of cell lines with lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma).
- Quantification of iNOS RNA, iNOS protein, and NO production.
- Assessment of endothelial cell proliferation and cell death.
Main Results:
- Antisense cells exhibited significantly reduced iNOS RNA and protein levels, and an 82% decrease in NO production compared to control cells after stimulation.
- Control cells showed significant NO production and inhibited proliferation upon stimulation.
- Antisense cells, producing minimal NO, maintained proliferation rates similar to unstimulated cells, with no observed differences in cell death.
Conclusions:
- Endogenously produced nitric oxide (NO) derived from inducible nitric oxide synthase (iNOS) directly inhibits endothelial cell proliferation.
- This study provides direct evidence clarifying the inhibitory role of iNOS-derived NO in endothelial cell growth.
- The developed antisense RNA approach offers a novel method to study NO function, overcoming limitations of previous studies using NO donors or non-specific inhibitors.
More Related Videos
Related Concept Videos
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Nitric Oxide Signaling Pathway

